Cutting-edge research and ambitious projects in the service of the fight against cancer
Translational research and clinical research are part of Jules Bordet Institute's DNA whose objective is to quickly bring research findings to the bedside.
The 2016-2019 scientific report reflects the spirit of commitment and collaboration of healthcare professionals, researchers and administrative support teams at the Institute, but also and above all, that of patients who trust the teams of the Bordet Institute and volunteer to participate in clinical trials as part of a true partnership.
For several decades, the Jules Bordet Institute has played a significant role in the promotion of university research by creating prestigious international research networks such as the European Organization for Research and Treatment of Cancer (EORTC), the Group international breast (BIG) and, more recently, the Oncodistinct network.
Research at the Institute will gain further momentum in the coming years with the construction of the new Jules Bordet Institute on the Université Libre de Bruxelles' campus alongside other research laboratories and the Erasme General Academic Hospital.
The new Jules Bordet Institute will offer a wide range of possibilities to research teams and current and future university or private partners, both in Belgium and abroad - all with the common objective of discovering new strategies to fight against cancer and its consequences for patients and their families!
The communication agency, Page in extremis is proud to have designed and produced the report. The agency is very honoured to serve for several years an organisation such as the Bordet Institute.
Page in extremis turns brands into valuable assets and ensures the alignment with their strategic objectives.
Interested in partnering with Page in extremis?
Based in Brussels, the communication agency makes brands conversational, helps organisations engage with their stakeholders and convey their messages.
For more information:
inextremis.be